Pharmacy Residency

PGY1 Pharmacy Residency Program

The CHA PGY1 Pharmacy Residency program started in July 2017 and is accredited by the American Society of Health-System Pharmacists (ASHP).

Program Purpose

The CHA PGY1 pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists who:

  • Are responsible for medication-related care of patients with a wide range of conditions
  • Are eligible for board certification
  • Are eligible for postgraduate (PGY2) pharmacy residency training

Overview & Application Process

The PGY1 pharmacy residency program recruits four PGY1 residents annually.

Applications are accepted through the Pharmacy Online Residency Centralized Application Service (PhORCAS). The deadline is December 30.

We participate in the National Matching Services Program.

Residency Policies

All offers of appointment to CHA sponsored training programs are specifically conditioned upon a criminal background investigation and a negative drug test (uses workplace standards, including chain of custody, marijuana is excluded from the testing). Background checks will be carried out by an agency on behalf of CHA. By signing the background check release form, prospective trainees are consenting to a background investigation. The drug test must be completed within 10 days of matching (all costs are covered by CHA). It will be conducted at CHA Occupational Health for those residents within 20 miles of Boston. All others will be tested at an outside facility arranged by CHA.